News
In recent years, the FDA has approved three complement inhibitors for gMG -- eculizumab (Soliris), ravulizumab (Ultomiris), ...
Wednesday is the last day for you to tell the Ohio Department of Transportation how it should reconnect the Lockland Split.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback